The Emergency Department as an Opportunity for Naloxone Distribution.

Published

Journal Article

Introduction:Substance use disorders, including opioid use disorders, are a major public health concern in the United States. Between 2005 and 2014, the rate of opioid-related emergency department (ED) visits nearly doubled, from 89.1 per 100,000 persons in 2005 to 177.7 per 100,000 persons in 2014. Thus, the ED presents a distinctive opportunity for harm-reduction strategies such as distribution of naloxone to patients who are at risk for an opioid overdose. Methods:We conducted a systematic review of all existing literature related to naloxone distribution from the ED. We included only those articles published in peer-reviewed journals that described results relating to naloxone distribution from the ED. Results:Of the 2,286 articles we identified from the search, five met the inclusion criteria and had direct relevance to naloxone distribution from the ED setting. Across the studies, we found variation in the methods of implementation and evaluation of take-home naloxone programs in the ED. In the three studies that attempted patient follow-up, success was low, limiting the evidence for the programs' effectiveness. Overall, in the included studies there is evidence that distributing take-home naloxone from the ED has the potential for harm reduction; however, the uptake of the practice remained low. Barriers to implementation included time allocated for training hospital staff and the burden on workflow. Conclusion:This systematic review of the best evidence available supports the ED as a potential setting for naloxone distribution for overdose reversal in the community. The variability of the implementation methods across the studies highlights the need for future research to determine the most effective practices.

Full Text

Duke Authors

Cited Authors

  • Gunn, AH; Smothers, ZPW; Schramm-Sapyta, N; Freiermuth, CE; MacEachern, M; Muzyk, AJ

Published Date

  • November 2018

Published In

Volume / Issue

  • 19 / 6

Start / End Page

  • 1036 - 1042

PubMed ID

  • 30429939

Pubmed Central ID

  • 30429939

Electronic International Standard Serial Number (EISSN)

  • 1936-9018

International Standard Serial Number (ISSN)

  • 1936-900X

Digital Object Identifier (DOI)

  • 10.5811/westjem.2018.8.38829

Language

  • eng